(TPB) Turning Point Brands - Overview
Sector: Consumer Defensive | Industry: Tobacco | Exchange: NYSE (USA) | Market Cap: 1.714m USD | Total Return: 12.9% in 12m
Avg Turnover: 35.7M
EPS Trend: 96.7%
Qual. Beats: 0
Rev. Trend: 51.0%
Qual. Beats: 0
Warnings
Earnings expected to drop: P/E 30.3 → Forward 64.1
Below Avwap Earnings
Tailwinds
No distinct edge detected
Turning Point Brands, Inc. (NYSE: TPB) is a Louisville-based manufacturer and distributor of branded consumer products, primarily serving the other tobacco products (OTP) market in the United States and Canada. The company operates through two core segments: Zig-Zag Products, which focuses on rolling papers and smoking accessories, and Stokers Products, which manages moist snuff and loose-leaf chewing tobacco brands. Its distribution network spans wholesale and retail channels, including convenience stores, mass merchandisers, and tobacco outlets.
The OTP sector is characterized by higher growth rates and lower regulatory tax burdens compared to the traditional combustible cigarette market. TPB utilizes an asset-light business model for its Zig-Zag segment, sourcing high-quality papers from long-term partners while maintaining strong brand equity in the niche cannabis accessory space. For a deeper look at these segment margins, investors can explore the financial tools on ValueRay. The companys recent strategic shifts include expanding its portfolio into tobacco-free nicotine pouches to align with evolving consumer preferences.
- Zig-Zag brand dominance in rolling papers drives premium segment revenue growth
- Stoker’s market share expansion in moist snuff offsets traditional tobacco volume declines
- Federal cannabis legalization progress impacts demand for smoking and rolling accessories
- Raw material cost fluctuations and supply chain logistics impact operating margins
- FDA regulatory actions on flavored tobacco products pose significant compliance risks
| Net Income: 55.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -9.29 > 1.0 |
| NWC/Revenue: 72.14% < 20% (prev 52.19%; Δ 19.95% < -1%) |
| CFO/TA 0.03 > 3% & CFO 20.5m > Net Income 55.4m |
| Net Debt (128.7m) to EBITDA (106.2m): 1.21 < 3 |
| Current Ratio: 5.87 > 1.5 & < 3 |
| Outstanding Shares: last quarter (19.5m) vs 12m ago 6.72% < -2% |
| Gross Margin: 56.77% > 18% (prev 0.55%; Δ 5.62k% > 0.5%) |
| Asset Turnover: 71.96% > 50% (prev 68.02%; Δ 3.93% > 0%) |
| Interest Coverage Ratio: 3.87 > 6 (EBITDA TTM 106.2m / Interest Expense TTM 25.4m) |
| A: 0.45 (Total Current Assets 418.2m - Total Current Liabilities 71.3m) / Total Assets 772.1m |
| B: 0.27 (Retained Earnings 209.7m / Total Assets 772.1m) |
| C: 0.15 (EBIT TTM 98.3m / Avg Total Assets 668.3m) |
| D: 0.54 (Book Value of Equity 207.9m / Total Liabilities 386.6m) |
| Altman-Z'' = 5.39 = AAA |
| DSRI: 0.73 (Receivables 27.5m/30.0m, Revenue 480.9m/384.0m) |
| GMI: 0.98 (GM 56.77% / 55.42%) |
| AQI: 0.82 (AQ_t 0.39 / AQ_t-1 0.47) |
| SGI: 1.25 (Revenue 480.9m / 384.0m) |
| TATA: 0.05 (NI 55.4m - CFO 20.5m) / TA 772.1m) |
| Beneish M = -3.15 (Cap -4..+1) = AA |
As of June 02, 2026, the stock is trading at USD 82.07 with a total of 422,275 shares traded.
Over the past week, the price has changed by -7.20%,
over one month by +5.27%,
over three months by -21.66% and
over the past year by +12.93%.
Turning Point Brands has received a consensus analysts rating of 4.75. Therefore, it is recommended to buy TPB.
- StrongBuy: 3
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 130 | 58.4% |
P/E Trailing = 30.3151
P/E Forward = 64.1026
P/S = 3.565
P/B = 4.7651
P/EG = 0.0499
Revenue TTM = 480.9m USD
EBIT TTM = 98.3m USD
EBITDA TTM = 106.2m USD
Long Term Debt = 293.9m USD (from longTermDebt, last quarter)
Short Term Debt = 4.64m USD (from shortTermDebt, last fiscal year)
Debt = 321.1m USD (from shortLongTermDebtTotal, last quarter) + Leases 16.2m
Net Debt = 128.7m USD (calculated: Debt 321.1m - CCE 192.4m)
Enterprise Value = 1.84b USD (1.71b + Debt 321.1m - CCE 192.4m)
Interest Coverage Ratio = 3.87 (Ebit TTM 98.3m / Interest Expense TTM 25.4m)
EV/FCF = 460.1x (Enterprise Value 1.84b / FCF TTM 4.01m)
FCF Yield = 0.22% (FCF TTM 4.01m / Enterprise Value 1.84b)
FCF Margin = 0.83% (FCF TTM 4.01m / Revenue TTM 480.9m)
Net Margin = 11.53% (Net Income TTM 55.4m / Revenue TTM 480.9m)
Gross Margin = 56.77% ((Revenue TTM 480.9m - Cost of Revenue TTM 207.9m) / Revenue TTM)
Gross Margin QoQ = 54.95% (prev 55.91%)
Tobins Q-Ratio = 2.39 (Enterprise Value 1.84b / Total Assets 772.1m)
Interest Expense / Debt = 7.91% (Interest Expense 25.4m / Debt 321.1m)
Taxrate = 18.03% (15.0m / 83.1m)
NOPAT = 80.6m (EBIT 98.3m * (1 - 18.03%))
Current Ratio = 5.87 (Total Current Assets 418.2m / Total Current Liabilities 71.3m)
Debt / Equity = 0.88 (Debt 321.1m / totalStockholderEquity, last quarter 365.8m)
Debt / EBITDA = 1.21 (Net Debt 128.7m / EBITDA 106.2m)
Debt / FCF = 32.13 (Net Debt 128.7m / FCF TTM 4.01m)
Total Stockholder Equity = 320.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.29% (Net Income 55.4m / Total Assets 772.1m)
RoE = 17.29% (Net Income TTM 55.4m / Total Stockholder Equity 320.6m)
RoCE = 16.00% (EBIT 98.3m / Capital Employed (Equity 320.6m + L.T.Debt 293.9m))
RoIC = 11.68% (NOPAT 80.6m / Invested Capital 690.4m)
WACC = 7.30% (E(1.71b)/V(2.04b) * Re(7.45%) + D(321.1m)/V(2.04b) * Rd(7.91%) * (1-Tc(0.18)))
Discount Rate = 7.45% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -20.0 | Cagr: -1.51%
[DCF] Terminal Value 73.10% ; FCFF base≈24.6m ; Y1≈21.5m ; Y5≈17.4m
[DCF] Fair Price = 7.78 (EV 279.3m - Net Debt 128.7m = Equity 150.6m / Shares 19.4m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 96.67 | EPS CAGR: 13.62% | SUE: 0.52 | # QB: 0
Revenue Correlation: 50.99 | Revenue CAGR: 5.25% | SUE: 0.62 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.55 | Chg30d=-40.33% | Revisions=-43% | Analysts=2
EPS next Quarter (2026-09-30): EPS=0.46 | Chg30d=-48.89% | Revisions=-43% | Analysts=2
EPS current Year (2026-12-31): EPS=2.14 | Chg30d=-40.06% | Revisions=-43% | GrowthEPS=-46.0% | GrowthRev=+12.9%
EPS next Year (2027-12-31): EPS=2.86 | Chg30d=-34.65% | Revisions=-43% | GrowthEPS=+33.6% | GrowthRev=+13.9%
[Analyst] Revisions Ratio: -43%